Table 1.

Characteristics of 11 HIV/HCV coinfected genotype 1 methadone maintenance study participants at start of HCV treatment.

Characteristic	Value
Demographic
Age, mean (range) (years)	46 (37–61)
Female	7 (64)
Race
Black, non-Hispanic	4
White, non-Hispanic	5
Hispanic	2
Substance use history
Injection drug use	11 (100)
Polysubstance drug use	11 (100)
Psychiatric history	11 (100)
Prescribed psychotropic medications pre-study	11 (100)
Depression	9 (82)
Anxiety	6 (55)
Panic disorder	1 (9)
Schizoaffective disorder	1 (9)
Post-traumatic stress disorder	1 (9)
HCV-related clinical values
Biopsy stage (Batts and Ludwig staging system)
Stage 1	1 (9)
Stage1–2 or 2	5 (45)
Stage 3	1 (9)
Stage 3–4 or 4	4 (36)
High HCV RNA (>400,000 IU/ml)	9 (82)
HIV-related clinical values
On HAART	10 (91)
CD4+ cell count, mean (range) (cells/μL)	498 (210–868)
Undetectable HIV RNA (<75 copies/ml)	9 (82)

Note: Data are no. (%) of participants, except where noted.